The aim of this study was to perform a controlled in situ analysis on the i
ncidence of apoptosis, investigate the expression of apoptosis-mediating pr
oteins, and determine the frequency of apoptotic CD4(+) and CD8(+) T cells
in Sjogren's syndrome (SS). The study was extended to patients with atrophy
-fibrosis (AF) not related to SS, as well as to a control group. Immunohist
ochemistry and the terminal deoxynucleotidyl transferase mediated dUTP digo
xigenin nick end labeling (TUNEL) method were applied to study the Fas and
FasL expression and the incidence of apoptosis in salivary glands (SG) from
patients with primary and secondary SS, AF, and controls. These methods we
re also combined to enable simultaneous detection of apoptotic and CD4(+) o
r CD8(+) T cells. Despite abundant expression of Fas and FasL in SS SG, apo
ptotic cells were not exceeding 1% in the foci of infiltrating mononuclear
cells (IMC). Double staining showed that the frequency of apoptosis was low
among both CD4(+) and CD8(+) T cells. Only a few TUNEL+ epithelial cells w
ere found in all patient groups. Fas was expressed predominantly on SS IMC,
single SS epithelial cells, and a few normal acinar cells, but not in AF S
G. Although FasL was present on SS and AF IMC and epithelial cells, it was
rarely detected in normal tissue. Consequently we demonstrate that Fas-indu
ced apoptosis among SS SG is a rare event. Our findings support an earlier
hypothesis indicating that IMC seem to be able to escape apoptosis, resulti
ng in foci of inflammatory cells. Notably, however, no obvious correlation
can be drawn to previous studies where a high incidence of apoptosis of epi
thelial cells was proposed as an important mechanism leading to decreased g
landular function, which is a hallmark of SS.